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An emerging concept in development is that tran-
scriptional poising presets patterns of gene expres-
sion in a manner that reflects a cell’s developmental
potential. However, it is not known how certain loci
are specified in the embryo to establish poised chro-
matin architecture as the developmental program
unfolds. We find that, in the context of transcriptional
quiescence prior to the midblastula transition in
Xenopus, dorsal specification by the Wnt/b-catenin
pathway is temporally uncoupled from the onset of
dorsal target gene expression, and that b-catenin
establishes poised chromatin architecture at target
promoters. b-catenin recruits the arginine methyl-
transferase Prmt2 to target promoters, thereby es-
tablishing asymmetrically dimethylated H3 arginine
8 (R8). Recruitment of Prmt2 to b-catenin target
genes is necessary and sufficient to establish the
dorsal developmental program, indicating that
Prmt2-mediated histone H3(R8) methylation plays a
critical role downstream of b-catenin in establishing
poised chromatin architecture and marking key
organizer genes for later expression.
INTRODUCTION
Transcriptional poising represents a widespread mechanism of
postinitiation control of gene expression that is observed in
metazoan biological model systems (see Margaritis and
Holstege, 2008; Saunders et al., 2006 for reviews). Establish-
ment of poised chromatin architecture at genetic loci allows for
a rapid and synchronous transcriptional response to environ-
mental and biological stimuli (Baugh et al., 2009; Boettiger and
Levine, 2009; Hargreaves et al., 2009; Muse et al., 2007;
Radonjic et al., 2005; Rougvie and Lis, 1988). Poised loci have
undergone successful preinitiation complex formation yet are
stalled at the transition from transcriptional initiation to elonga-
tion (Saunders et al., 2006). Thus, they are marked by covalent220 Developmental Cell 19, 220–231, August 17, 2010 ª2010 Elseviehistone modifications (acetylation of lysine 9 and 14, and trime-
thylation of lysine 4 on histone H3, H3K9/14ac, and H3K4me3,
respectively) and a phosphorylated form of the large subunit
of the RNA polymerase holoenzyme (Pol II CTDpSer5) that
correlates with transcriptional initiation prior to the onset of
mRNA expression (Guenther et al., 2007; Margaritis and Hol-
stege, 2008). Remarkably, in the context of embryonic develop-
ment, poised chromatin architecture is established within
multipotent precursor cells in a manner that reflects the develop-
mental potential of the lineage (Bernstein et al., 2006; Guenther
et al., 2007; Hammoud et al., 2009; Vastenhouw et al., 2010;
Zeitlinger et al., 2007). However, it is not well understood
how certain loci are specified to establish poised chromatin
architecture as the developmental program unfolds.
The earliest events in embryogenesis are controlled by
maternal factors until the activation of the zygotic genome. In
Xenopus, Drosophila, and Zebrafish, zygotic genome activation
occurs several hours and cell divisions after fertilization, at the
midblastula transition (MBT) (Edgar and Schubiger, 1986;
Kane and Kimmel, 1993; Newport and Kirschner, 1982).
However, while zygotic transcription is constrained before the
MBT, essential steps in embryonic patterning are accomplished
before the MBT and embryos emerge from this period having
begun the process of regional specification. In particular, the
Wnt/b-catenin pathway mediates the earliest cell fate decision
in amphibian (and teleost) embryogenesis, the establishment
of the dorsoventral axis. Dorsal specification by the Wnt/b-cat-
enin pathway takes place under conditions of global transcrip-
tional repression, prior to the MBT (Heasman et al., 2000; Kao
et al., 1986; Yamaguchi and Shinagawa, 1989; Yang et al.,
2002b).While b-catenin is required for the transcription of a small
set of genes that are expressed before the MBT (Yang et al.,
2002b), the critical Wnt target genes that direct dorsal develop-
ment are silent until the MBT. Notably, b-catenin can interact
with numerous factors that direct both chromatin modifica-
tion and RNA Pol II recruitment to promoters (reviewed in
Mosimann et al., 2009), including factors that establish both
H3K9/14ac and H3K4me3. These observations raise the possi-
bility that b-catenin functions during the preMBT period to
establish a heritable, transcriptionally poised state that results
in the later expression of dorsal determinants such as siamois
and xnr3.r Inc.
Figure 1. b-Catenin Target Genes Are
Poised for Expression before the MBT
(A) Onset of expression of maternal b-catenin
target genes (Siamois, Xnr3, Xnr5, and Xnr6).
Maternally expressed Ornithine decarboxylase
(Odc) is shown as a control for loading. Odc
(-RT) indicates no reverse transcriptase, as a
control for genomic DNA contamination.
(B) Embryos were injected at the two-cell stage
with the b-catenin morpholino (Bii–Biv) and subse-
quently at the four-cell stage (two dorsal blasto-
meres) with 2 pg siamois (Biii) or 300 pg b-catenin
(Biv) mRNAs. The frequency of each representa-
tive phenotype is indicated.
(C) Embryos were injected into two dorsal blasto-
meres at the four-cell stage with 500 pg DNTcf3-
GR mRNA. Wnt/b-catenin activity was inhibited
by addition of dexamethasone (Dex) to the culture
medium at the indicated stages. Siamois, Xnr3,
and ODC mRNA expression was measured by
RT-PCR at stage 10.
(D) Left panel: Occupancy of initiating (CTD pSer5)
RNA Pol II in the promoter-proximal regions of the
Siamois and Xnr3 loci before (1000-cell stage) or
after (Stage 9) the onset of expression as
measured by ChIP-QPCR. Right panel: Elongating
(CTD pSer2) RNA Pol II associated with the 30 CDS
of the same panel of genes at the same time
points. Binding of RNA Pol II at Xnr6, which is
expressed at both stages, is a positive control.
Pooled data from three independent experiments
are presented as a percentage of input chromatin
to facilitate comparison between the 1000-cell
stage and Stage 9. The average signal (0.02%
input) from a negative control (IgG) ChIP is marked
as a dotted line. Error bars are SEM from three
independent experiments.
(E) PreMBT occupancy of maternal b-catenin
target promoters (Siamois, Xnr3, and Xnr5) or a
zygotic b-catenin target promoter (Myf5) by either
H3K9/14ac or b-catenin was observed by ChIP on
1000-cell stage embryos. Myosin light chain 2
(Mlc2): negative control locus. ‘‘Input’’ indicates
chromatin prior to ChIP.
(F) Promoter occupancy by b-catenin or H3K4me3
measured by ChIP on 1000-cell embryos.
See also Figure S1.
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target genes before the MBT and report that b-catenin contrib-
utes to the establishment of poised chromatin architecture,
thus priming target promoters for activation at the onset of zy-
gotic gene expression. Before the MBT, b-catenin target
promoters associate with RNA Pol II (CTDpSer5) and aremarked
by H3K9/14ac and H3K4me3, independently of their level of
mRNA expression. Deposition of H3K4me3, in particular,
requires both preMBT b-catenin and RNA Pol II function. Impor-
tantly, during dorsal specification, b-catenin recruits the arginine
methyltransferase Prmt2 to target gene promoters, which results
in the asymmetric dimethylation of histone H3 arginine 8.
Recruitment of Prmt2 to b-catenin target gene promoters is
both necessary and sufficient to establish the dorsal gene
expression program. We therefore provide direct evidence
for a complex pretranscriptional mechanism at work in early
embryos to preset patterns of gene expression and provide anDevelopinitial analysis of chromatin architecture during this critical period
of development.
RESULTS
Dorsal Specification by b-Catenin Is Temporally
Uncoupled from the Onset of Target Gene Expression
The maternal Wnt/b-catenin pathway in Xenopus (and zebrafish)
specifies dorsal cell fates before the MBT under conditions of
global transcriptional repression. Two classes of dorsal genes
are expressed in response to maternal b-catenin (Yang et al.,
2002b): genes such as siamois and xnr3 are expressed at the
MBT (Figure 1A), whereas genes exemplified by xnr5 and xnr6
are transcribed as early as the 256-cell stage, bypassing preMBT
global transcriptional repression (Figure 1A).
Maternal b-catenin is required to activate the dorsal gene
expression program (Heasman et al., 2000), but it is not yet clearmental Cell 19, 220–231, August 17, 2010 ª2010 Elsevier Inc. 221
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Siamois induces complete secondary axes and rescues dorsal
development in ventralized embryos (Lemaire et al., 1995),
whereas combined loss of siamois and the closely related
gene twin blocks dorsal development (Ishibashi et al., 2008;
Laurent et al., 1997), indicating that siamois and twin play essen-
tial, instructive roles in dorsal induction. However, these experi-
ments leave open the possibility that dorsal development
depends on additional targets of maternal Wnt/b-catenin
signaling. To test whether siamois expression is sufficient for
dorsal development in b-catenin-deficient embryos, b-catenin
was depleted by injection of a morpholino oligonucleotide
(bMO), which blocked dorsal development (Figure 1Bii), as
described (Heasman et al., 2000); expression of siamois in these
embryos rescued dorsal development to the same extent as
b-catenin itself (Figures 1Biii and 1Biv). Therefore, establishment
of zygotic siamois expression represents an essential patterning
event driven by the maternal Wnt/b-catenin pathway.
It is paradoxical, then, to consider how a transcription factor
such as b-catenin functions during a period of global transcrip-
tional repression. One possibility is that, while b-catenin is
present throughout cleavage stages, it only functions at the
MBT to activate target genes such as siamois and xnr3. This
seems unlikely, as b-catenin is required for preMBT transcription
of xnr5 and xnr6 and dorsal specification by b-catenin is
complete by the 32-cell stage (Yang et al., 2002b). However,
those experiments did not directly address the requirement for
early b-catenin function in the induction of siamois and xnr3 at
the MBT. We therefore inhibited Wnt pathway activity at discrete
times before the MBT using a dexamethasone-inducible form
of Tcf3 that is unable to bind b-catenin (DNTcf3-GR) and
thereby inhibits endogenous b-catenin/Tcf3 transactivation.
While inhibition of b-catenin/Tcf3 transactivation at the four-
cell stage significantly reduces siamois and xnr3 expression after
the MBT, inhibition at the 32-cell stage has little or no effect
(Figure 1C). This indicates that, as early as the 32-cell stage,
dorsal cell fates have been specified and ‘‘locked-in,’’ as the
embryo is no longer sensitive to inhibition of b-catenin/Tcf3
transactivation. Notably, six cell divisions separate the 32-cell
stage from the MBT, indicating that the information imparted to
promoters must be inherited through multiple cell divisions
following dorsal specification. We thus conclude that dorsal
specification by b-catenin is temporally uncoupled from the
onset of dorsal target gene expression.
b-Catenin Establishes Poised Chromatin Architecture
at Target Promoters before the MBT
We next hypothesized that b-catenin binds to target promoters
and poises them for activation before the MBT so that they
may be expressed following the large-scale activation of the
zygotic genome. In general, transcriptionally poised loci are
bound by initiating (CTD pSer5) RNA Pol II and marked by
H3K9/14ac and H3K4me3 prior to the onset of transcription
(Guenther et al., 2007). To test whether these promoters
bear marks of poised chromatin architecture before the onset
of mRNA expression, we performed chromatin immunoprecipi-
tation (ChIP) assays (Blythe et al., 2009) for these marks of
poised loci and for b-catenin in 1000-cell stage embryos, the
earliest preMBT time point (prior to the onset of siamois and222 Developmental Cell 19, 220–231, August 17, 2010 ª2010 Elseviexnr3 expression) where it is feasible, in our hands, to perform
ChIP (Figures 1D–1F).
Although transcription is constrained before the MBT, phos-
phorylated forms of RNA Pol II corresponding to both initiating
(CTD pSer5) and elongating (CTD pSer2) are detected before
theMBT inwhole embryo lysates (see Figure S1 available online),
albeit at lower levels than after the MBT. To assess whether
initiating or elongating RNA Pol II associates with b-catenin
target genes, we performed ChIP against CTD pSer5- and
CTD pSer2-RNA Pol II (Figure 1D), comparing samples collected
before the onset of siamois and xnr3 expression (1000 cell) with
those collected after the onset of expression (Stage 9, blastula)
(see Figure 1A). As a positive control, we compared RNA Pol II
occupancy at the xnr6 locus, which is transcribed during both
the 1000-cell stage and at Stage 9 (see Figure 1A). As expected,
similar levels of both forms of RNA Pol II are found associated
with the xnr6 locus before and after theMBT (Figure 1D). Consis-
tent with our hypothesis, the siamois and xnr3 loci are bound by
initiating RNA Pol II before the onset of their expression, at levels
similar to those found after the MBT (Figure 1D, left panel);
however, the amount of elongating RNA Pol II associated with
siamois and xnr3 increases after theMBT (Figure 1D, right panel).
These observations indicate that the siamois and xnr3 loci are
bound by initiating RNA Pol II prior to the onset of their expres-
sion, as expected for poised loci.
In addition to binding the promoters of preMBT expressed
genes, xnr5 and xnr6, b-catenin also binds the siamois and
xnr3 promoters before the MBT (Figures 1E and 1F). We also
tested whether b-catenin could bind later (zygotic Wnt) targets
during preMBT stages. Before the MBT, b-catenin does not
bind a cluster of Tcf/Lef binding sites flanking the zygotic Wnt
target gene myf5 (Yang et al., 2002a), although it binds these
sites after the MBT (Figure 1E and data not shown), indicating
that b-catenin binding is restricted to maternal Wnt target genes
before the MBT. The siamois and xnr3 promoters are also
marked by H3K9/14ac before the onset of their expression
(Figure 1E). However, while b-catenin binding is restricted to
maternal Wnt target genes, H3K9/14ac binding is more widep-
read: the promoters of all genes tested—maternal and zygotic
b-catenin target genes and a negative control locus,myosin light
chain 2 (mlc2)—contain H3K9/14ac before the MBT. Finally,
maternal Wnt target promoters are marked before the MBT
with another marker of poised loci, H3K4me3 (Figure 1F). Taken
together, these data demonstrate that the b-catenin target genes
siamois and xnr3 arrive at the MBT poised for expression.
These observations raise the possibility that b-catenin plays
an instructive role in establishing poised chromatin architecture
at the siamois and xnr3 loci. In support of this hypothesis, deple-
tion of b-catenin reduces H3K4me3 at the siamois and xnr3
promoters (Figure 2A). In addition, inhibition of b-catenin/Tcf3
transactivation by DNTcf3 reduces b-catenin binding to the
siamois and xnr3 promoters and blocks H3K4me3 (Figure 2B).
In contrast, DNTcf3 has less of an effect on H3K9/14ac at the
poised siamois and xnr3 promoters, suggesting that preMBT
acetylation at siamois and xnr3 is established, at least in part,
independently of b-catenin.
Dorsal specification by b-catenin prior to the 32-cell stage is
sensitive to inhibition of RNA Pol II (Yang et al., 2002b). Deposi-
tion of H3K4me3 at promoters also correlates with occupancy ofr Inc.
Figure 2. b-Catenin and RNA Pol II Establish
H3K4me3 at Poised Promoters
(A) ChIP for H3K4me3 in 1000-cell control and b-catenin-
depleted (b-MO) embryos. All sibling b-MO embryos were
completely ventralized at later stages (not shown).
(B) H3K4me3, but not H3K9/14ac, requires b-catenin
function. MBT-stage control (upper panel for each gene)
and DNTcf3 mRNA-injected (500 pg, lower panels)
embryos were subjected to ChIP for b-catenin, H3K9/
14ac, and H3K4me3.
(C) 1000-cell stage control and b-catenin-depleted (b-MO)
embryos were subjected to ChIP for RNA Pol II (CTD
pSer5). All sibling b-MO embryos were completely ventral-
ized at later stages (not shown).
(D) MBT-stage control (upper panels) and a-amanitin
injected (10 ng, lower panels) embryos were subjected
to ChIP for b-catenin, H3K9/14ac, and H3K4me3.
Developmental Cell
b-Catenin Primes Organizer Gene Expressioninitiating polymerase (Ng et al., 2003), and RNA Pol II is also
required for b-catenin-mediated H3K4me3 in Drosophila (Parker
et al., 2008).We therefore testedwhetherpreMBTRNAPol II func-
tion is necessary for the establishment of other marks of poised
loci. Knocking down b-catenin has no effect on the occupancy
of initiating RNA Pol II at the poised siamois and xnr3 promoters
(Figure 2C), indicating that initiating RNA Pol II is established at
poised loci independently of b-catenin. In addition, RNA Pol II
function is not required for binding of b-catenin; however, inhibi-
tion of Pol II greatly reduces H3K4me3 at the siamois and xnr3
promoters, but does not affect H3K9/14ac (Figure 2D).
In summary, we find that the maternal Wnt target genes
siamois and xnr3 arrive at the MBT poised for activation. b-cate-
nin functions, in collaboration with RNA Pol II, to establish the
H3K4me3 mark in particular, whereas these promoters are
bound by initiating RNA Pol II and H3K9/14ac even when Wnt/
b-catenin signaling is inhibited. We conclude that b-catenin is
required for the establishment of poised chromatin architecture
at these loci, thereby priming them for activation at the MBT.
b-Catenin Associates with a Histone H3(R8)
Methyltransferase Activity in Early Xenopus Embryos
We next hypothesized that, during dorsal specification (between
the 4- and 32-cell stage), b-catenin interacts with a chromatin-
modifying activity that functions to establish poised chromatin
architecture at target promoters. To identify such a factor, we
immunoprecipitated b-catenin from 8- to 32-cell stage embryos
and performed in vitro histone acetyl- or methyl-transferase (HAT
or HMT) assays. During dorsal specification, b-catenin interactsDevelopmental Cell 19, 2with a HMT activity that specifically methylates
histone H3 but not H4 (Figure 3A). Under these
assay conditions, we were unable to detect an
associated HAT activity (Figure S2A). b-catenin
is predicted to interact with several functionally
different macromolecular complexes (Gottardi
and Gumbiner, 2001). We determined that b-cat-
enin interacts with this HMT activity in a high
molecular weight complex that is unique to
a subset of cellular b-catenin (Figures S2B–S2D).
To identify the residue on histone H3 targeted
by the b-cat/HMT complex, we performedb-catenin IP/HMT assays using as the substrate recombinant
H3.3 (rH3.3) with alanine pointmutations at candidate target resi-
dues (Figure 3B) previously shown to bemethylated: arginines (R)
2, 8, 17, 26 and lysines (K) 4 and 9 (Bedford and Clarke, 2009;
Kouzarides, 2007). As with H3, the b-cat/HMT significantly
methylates rH3.3(WT) over background. Importantly, mutation
of K4 has no effect on H3 methylation, suggesting that the
H3K4me3 observed at the poised siamois and xnr3 promoters
is indirectly established by b-catenin (Figures 1F, 2A, and 2B;
see Discussion). These observations also rule out R2, 17, and
26 as the major methyl acceptor sites for the b-cat/HMT. In
contrast, mutation of either R8 or K9 prevents H3 methylation
by the b-cat/HMT. Similarly, while the b-cat/HMT methylates
an unmodified H3 (1-15) peptide (Figure 3C, lane 2) to a similar
level as full-length H3 (data not shown), premodification of H3
peptides at either R8 (asymmetric dimethyl) or K9 (acetyl and
trimethyl) prevents methylation by the b-cat/HMT (Figure 3C,
lanes 3, 6, and 7). Thus, in addition to targeting either position
R8 or K9, the b-cat/HMT is also sensitive to the modification
status of these residues.
H3K9methylation is generally associated with heterochromatin
and transcriptional repression (Kouzarides, 2007) and is therefore
an unlikely target residue for the b-cat/HMT. Several ChIP exper-
iments failed to detect H3K9me2 and –me3 at the siamois and
xnr3 promoters between the 1000-cell stage and MBT, and
H3K9me1 levels were not sensitive to stabilization of b-catenin
by LiCl treatment (Figure 3D and data not shown). On the other
hand, the effect of H3R8 methylation on transcriptional control is
poorly understood. To test whether b-catenin activity regulates20–231, August 17, 2010 ª2010 Elsevier Inc. 223
Figure 3. b-Catenin Associates with a
Histone H3(R8) Methyltransferase before
the MBT
(A) b-catenin was immunoprecipitated from
16-cell embryos and HMT activity was visualized
by fluorography (1 day exposure) for incorporation
of [3H] methyl groups into calf thymus histones
(top panel). Equal loading of histones is shown
by Coomassie staining (lower panel). ‘‘Input’’
represents HMT activity in embryo lysates, with
activity toward both H3 and H4.
(B) b-catenin IP/HMT assays were performed on
either wild-type (WT) recombinant H3.3 or H3.3
with the indicated point mutations.
(C) b-catenin IP/HMT assays were performed
on peptides corresponding to unmodified H3
(aa 1–15, lanes 1 and 2), asymmetrically dimethy-
lated R8 (aa 1–15, lane 3), unmodified H3 (aa 1–21,
lanes 4 and 5), acetylated K9 (aa 1–20, lane 6), and
trimethylated K9 (aa 1–24, lane 7).
(D) MBT-stage control and lithium chloride treated
(LiCl, 300 mM for 10 min, 1 hr prior to harvest)
embryos were subjected to ChIP for either
H3K9me1 or H3K9me3.
(E) ChIP was performed as described in (D), using
instead antibodies to either H3R8me2a or
H3R8me2s (Pal et al., 2004).
(F) ChIP was performed on 1000-cell control and
b-catenin knockdown (b-MO) embryos with the
Active Motif H3R8me2a antiserum.
See also Figure S2.
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that specifically detects asymmetrically dimethylated H3R8
(H3R8me2a) (Figures S2E and S2F) and confirmed that the
H3R8me2a modification occurs in vivo. Subsequently, we
measured H3R8 methylation at the siamois promoter by ChIP.
H3R8me2a associates with the siamois promoter at the MBT
and symmetric H3R8 dimethylation (H3R8me2s) is not detected
(Figure 3E). This result was confirmed with an independent source
of anti-H3R8me2a antibody (Figures 3F and S2G). To test whether
association of H3R8me2a correlates with b-catenin activity, we
exposed preMBT embryos to a pulse of LiCl, which stabilizes
b-catenin throughout the embryo. One hour after the LiCl pulse,
H3R8me2a increased dramatically at the siamois and xnr3
promoters (Figure 3E and data not shown), indicating that
asymmetric H3R8 methylation correlates with preMBT b-catenin
activity. Furthermore, knockdown of b-catenin reduced
H3R8me2a at the siamois and xnr3 promoters before the MBT224 Developmental Cell 19, 220–231, August 17, 2010 ª2010 Elsevier Inc.(Figure 3F). Thus, the b-cat/HMT asym-
metrically dimethylates H3R8 and is sensi-
tive to the modification state of H3K9. Our
results also indicate that b-catenin inter-
acts with a type I (asymmetric) arginine
HMT in early Xenopus embryos.
b-catenin Recruits the H3R8
Methyltransferase Prmt2
to Target Loci
Weundertookacandidate-basedapproach
to identify theb-catenin-associatedarginineHMT. Of the ten members of the protein arginine methyltransferase
(Prmt) family, threehavebeenshowntomethylatehistoneH3 invitro:
Carm1, Prmt5, and Prmt6 (Guccione et al., 2007; Hyllus et al., 2007;
Pal et al., 2004; Schurter et al., 2001). Of these, only the type II,
symmetric HMT Prmt5 specifically targets R8 (Pal et al., 2004). By
expressing myc-tagged Prmts in Xenopus embryos and immuno-
precipitating b-catenin, we found that none of the Prmts known to
methylate H3 (Carm1, Prmt5, and Prmt6) copurified with b-catenin
(data not shown). However, Prmt2, which is most closely related
to Carm1 and Prmt6, coimmunoprecipitates with b-catenin
(Figure 4A). Although recombinant b-catenin and Prmt2 do not
interact directly in vitro (data not shown), GST-tagged Prmt2 inter-
acts with b-catenin in Xenopus embryo lysates in a temperature
andATP-dependentmanner (Figure 4B). Coupledwith our observa-
tion that the b-cat/HMT complex is large (Figures S2B–S2D), we
propose that an unknown catalytic activity is required for Prmt2
and b-catenin to interact within a large macromolecular complex.
Figure 4. b-Catenin Interacts with the Histone H3
(R8) Methyltransferase Prmt2
(A) Myc-tagged mouse Prmt2 (500 pg) was expressed in
Xenopus embryos and embryo lysates (early blastula)
were immunoprecipitated with anti-b-catenin or preim-
mune serum and subjected to western blot with either
anti-myc (upper panel) or anti-b-catenin antibodies.
(B) PreMBT embryo lysates were incubated for 1 hr with
GST-Prmt2 beads at 4C or 30C and with ATP or the
nonhydrolyzable ATP analog AMP-PNP. Bound proteins
were eluted and b-catenin was visualized by western
blot (upper panel). GST beads alone were used as a
negative control and the relative amounts of bait proteins
in each lane were visualized by Coomassie staining (lower
panel, arrowheads). ‘‘Input’’ indicates nonfractionated
input embryo lysate.
(C) Endogenous Prmt2 from mouse embryonic stem cells
was subjected to an IP/HMT assay using recombinant
H3.3 as a substrate. Rabbit IgG was the negative control.
(D) Activity of Myc-Prmt2 from 32- to 128-cell Xenopus
embryos was measured by IP/HMT assay using wild-
type (WT) or R8A histone H3.3 as substrates. Noninjected
embryos served as negative controls.
(E) Wild-type or b-MO injected 1000-cell embryos
expressing Myc-Prmt2 were subjected to ChIP using the
anti-Myc-tag antibody. Noninjected embryos served as
a negative control. The specificity of ChIP was confirmed
by including a 200-fold excess of the Myc-peptide
(lane 3) in the IP.
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Carm1 and Prmt6, but its substrate preference has not been
determined because recombinant Prmt2 has little to no activity
in vitro (Lakowski and Frankel, 2009; Scott et al., 1998). Also, to
our knowledge, HMT activity associated with endogenous
Prmt2 has not been reported. Interestingly, endogenous Prmt2
immunoprecipitated from mouse embryonic stem cells methyl-
ates histone H3 (Figure 4C). Likewise, myc-Prmt2 expressed in
Xenopus embryos methylates histone H3, and this activity
requires H3R8 (Figure 4D). In these experiments, purified Prmt2
has HMT activity toward histone H3, reflecting either the activity
of Prmt2 itself or the activity of another HMT that coimmunopre-
cipitates with Prmt2. Further investigation will be required to
determine the factors that regulate endogenous Prmt2 catalysis.
Importantly, Prmt2 binds the siamois promoter in preMBT
embryos (Figure 4E) as determined by ChIP. Furthermore, b-cat-
enin knockdown reduced Prmt2 occupancy at the siamois
promoter, suggesting that b-catenin recruits Prmt2 to target
promoters. We therefore conclude that Prmt2 represents the
HMT activity that associates with b-catenin in early Xenopus
embryos based on the observations that b-catenin interacts
with Prmt2, Prmt2 has a HMT activity directed at H3 that is sensi-
tive to the R8A mutation, and b-catenin recruits Prmt2 to target
genes during the preMBT period.
Maternal Prmt2 Is Necessary for Dorsal Specification
Based on the above observations, we predicted that recruitment
of Prmt2 by b-catenin to dorsal target genes would be essentialDevelopfor specifying the dorsal developmental program. Therefore, we
tested whether loss of Prmt2 function in early embryos would
affect dorsal specification. Xenopus Prmt2 is expressed mater-
nally, and knockdown of Prmt2 in fertilized embryos only weakly
affects expression of siamois and xnr3 (data not shown). There-
fore, we knocked down Prmt2 in oocytes and generated mater-
nally depleted Prmt2 (prmt2-) embryos by the host transfer
method (Mir and Heasman, 2008). Prmt2- embryos generated
by antisense DNA are impaired in dorsal development (Fig-
ure 5A). These embryos develop with a range of dorsoventral
morphologies, displaying completely ventralized, anterior-trun-
cated (partially ventralized), and normal phenotypes within single
clutches (Figures 5A and 5B) (n = 66 embryos from six indepen-
dent experiments). Importantly, depletion of Prmt2 reduces the
expression of both siamois and xnr3 following the MBT
(Figure 5C; Figures S3A and S3B), indicating that Prmt2 function
is necessary for the activation of maternal Wnt/b-catenin depen-
dent transcription. These ventralized phenotypes are specific to
loss of Prmt2 function, as expression of mouse Prmt2 mRNA in
prmt2- embryos rescues siamois and xnr3 expression and
partially rescues the morphological phenotype (Figures 5B and
5C, n = 26 from three independent experiments). We also repli-
cated the knockdown of siamois and xnr3 with a translational
blocking morpholino oligonucleotide against Prmt2 (Figure S3A).
However, while the morpholino generated a more severe knock-
down of siamois and xnr3, it was more difficult to generate viable
MBT-stage embryos, possibly due to a general requirement for
Prmt2 in the regulation of chromatin structure beyond itsmental Cell 19, 220–231, August 17, 2010 ª2010 Elsevier Inc. 225
Figure 5. Maternal Prmt2 Is Necessary for Dorsal Specification
(A and B) Transplantation and fertilization of maternal Prmt2-depleted (prmt2-)
oocytes results in a range of ventralized tadpole-stage phenotypes (A, lower
panel) compared with controls, which develop normally (A, top panel). The
mean frequency of phenotypes arising from maternal Prmt2 depletion is
plotted in B (see text for details). The frequency of ventralized embryos
(both partial and complete) is reduced by co-injection of Prmt2 mRNA
(‘‘prmt2-/+mRNA’’).
(C) Blastula stage (stage 9) siamois and xnr3 expression was measured in
prmt2- and rescued (‘‘prmt2- (+mRNA)’’) host transfer embryos as compared
with control (nondepleted) and Prmt2mRNA injected embryos. As a control for
the efficiency of knockdown, prmt2 was measured. Note that the rescuing
mRNA (1 ng of mouse Prmt2, injected into oocytes) is not amplified by the
Xenopus prmt2 primers used here. Expression of rescuing mRNA was
confirmed by western blot (not shown). Embryos expressing Prmt2 mRNA
alone developed identically to controls, with no dorsoventral defects
(not shown).
See also Figure S3.
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DNA yielded a partial knockdown of maternal prmt2 message
that allowed for recovery of viable embryos at the expense of
the severity of the phenotype (Figures 5 and S3). Nonetheless,226 Developmental Cell 19, 220–231, August 17, 2010 ª2010 Elseviethese observations strongly support the conclusion that recruit-
ment of Prmt2 to dorsal gene promoters is a necessary step in
establishing the dorsal gene expression program.
Directing Prmt2 to b-Catenin Target Promoters
Is Sufficient to Drive Dorsal Specification
in the Absence of b-Catenin
b-catenin interacts with chromatin via the Tcf/Lef family of
DNA-binding factors (Behrens et al., 1996; Molenaar et al.,
1996), and previous investigations have exploited this interaction
to target factors of interest to Tcf/Lef binding sites and test
their effects on target gene expression (Vleminckx et al., 1999).
Therefore, we generated chimeric proteins (Figure 6A) between
Prmt2 and the DNA binding domain of Lef-1 (DNLef1) to direct
Prmt2 to target genes and evaluate its effect on dorsal specifica-
tion. Chimeras between DNLef1 and a SAM-binding mutant of
Prmt2 (Prmt2GG) (Qi et al., 2002), or wild-type Carm1, Prmt5,
and Prmt6 were also generated as controls. All chimeric proteins
were expressed to similar levels in blastula stage embryos
(Figure 6B; data not shown).
Recruitment of Prmt2 to b-catenin target genes is sufficient to
specify the dorsal developmental program, as expression of the
Prmt2:DNLef1 chimera in ventral blastomeres converts them to
dorsal progenitors (n = 172, Figure 6B), similar to activation of
Wnt/b-catenin signaling. Ventral expression of the DNLef1 DNA
binding domain alone did not induce secondary axes (n = 31,
data not shown). To determine whether Prmt2-induced dorsal
cell fates are dependent on its catalytic activity, we tested the
ability of the Prmt2GG mutant to induce secondary axes. At
similar levels of expression, Prmt2GG:DNLef1 induced signifi-
cantly fewer secondary axes (n = 81) (Figure 6B, histogram),
and these axes were typically truncated (Figure 6B, photo)
compared with those observed with Prmt2:DNLef1, indicating
that dorsal specification by Prmt2 is dependent on its HMT
activity. However, Prmt2GG nonetheless conferred some
dorsal axis inducing activity; therefore, we cannot rule out
that additional factors that interact with Prmt2 contribute to
Prmt2-dependent dorsal specification.
In a complementary approach, we tested whether
Prmt2:DNLef1 could rescue b-catenin loss of function. Embryos
depleted for b-catenin develop with a ventralized phenotype
(Figure 6Cii; see also Figure 1Bii), whereas expression of
Prmt2:DNLef1 in b-catenin-depleted embryos restores the full
range of dorsal and anterior structures (Figure 6Ciii), remarkably
similar to control embryos (Figure 6Ci), albeit typically with a
single eye (86% rescue, n = 172). The anterior defects in
Prmt2:DNLef1-rescued b-MO embryos could result from activa-
tion of the posteriorizing zygoticWnt target genes, as expression
of Prmt2:DNLef1 alone in dorsal blastomeres did not affect
dorsal specification, but did induce a weak posteriorized pheno-
type (data not shown, n = 29). Importantly, expression of
Prmt2:DNLef1 in b-MO embryos rescues organizer gene expres-
sion, whereas the DNLef1 DNA binding domain alone has
minimal activity (Figure 6D).
To assess the specificity of Prmt2:DNLef1, we also tested
whether other Prmts could rescue dorsal specification in b-cat-
enin-depleted embryos. Prmt5 shares target residue specificity
with Prmt2 but symmetrically dimethylates H3R8 (Pal et al.,
2004), and Prmt5:DNLef1 is unable to rescue dorsalr Inc.
Figure 6. Directing Prmt2 to b-Catenin Target Gene Promoters Is
Sufficient to Drive Dorsal Specification
(A) Schematic of the Prmt2:DNLef1 chimeric construct. To direct Prmt2 to
Tcf/Lef DNA binding sites, the DNA-binding HMG domain of mouse Lef1
was fused to the C terminus of mouse Myc-Prmt2.
(B) Four-cell embryos were injected with either wild-type (WT) or catalytically
inactive SAM-binding mutant G159,161R (GG) Prmt2:DNLef1 into two ventral
blastomeres. Phenotypes (left panel) were scored at late-neurula/early tailbud
stages. Mean frequency of secondary axis formation (both fully and partially
extended) resulting from expression of wild-type or GG mutant Prmt2:DNLef1
is plotted on the right. n = 197, 172, and 81 embryos for control, WT, and GG
mutant, respectively. Error bars are SEM; p = 0.017 (two-tailed Student’s t test)
for the four independent trials where WT and mutant were compared directly.
Equal expression of wild-type and GG mutant Prmt2:DNLef1 was verified by
western blot for the myc tag (inset).
(C) Embryos were depleted for b-catenin (b-MO, Cii–Civ) and subsequently
injected with 500 pg of either Prmt2:DNLef1 (Ciii) or Prmt5:DNLef1 (Civ)
mRNA. Rescue of b-MO-induced ventralization (Cii) was measured at tadpole
stages. Note the rescue of the anterior-most, dorsally derived cement gland
and eye in (Ciii, compared with control, noninjected embryos (Ci). The percent-
ages in the upper right corner of each panel indicate the frequency at which the
phenotypes shown were observed.
(D) Embryos were depleted for b-catenin (b-MO) and subsequently injected
with Prmt2:DNLef1 or DNLef1 mRNA as in (C). Expression of Siamois and
Xnr3 was measured by RT-PCR at stage 10. EF1a expression is shown as a
loading control.
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Developspecification in b-catenin-depleted embryos (Figure 6Biv, 0%
Rescue, n = 31). On the other hand, the robust transcriptional
activator Carm1 asymmetrically methylates H3 R2, R17, and
R26, with only a weak activity toward R8 (Chen et al., 2000;
Schurter et al., 2001). Expression of Carm1:DNLef1 is toxic to
embryos shortly after gastrulation, so phenotypic rescue could
not be scored. However, at gastrula stages, Carm1:DNLef1
does not rescue siamois and xnr3 expression (Figure 6D). Finally,
Prmt6, which targets H3R2 (Guccione et al., 2007; Hyllus et al.,
2007), also did not rescue dorsal specification (not shown, 0%
rescue, n = 30). Thus, of the Prmts tested, only the recruitment
of Prmt2 to b-catenin target promoters is sufficient to rescue
dorsal specification, demonstrating the unique role of Prmt2 in
the regulatory events that establish the transcriptional network
driving dorsal development in Xenopus embryogenesis.
DISCUSSION
In this work, we demonstrate that dorsal specification by the
Wnt/b-catenin pathway drives transcriptional poising at Wnt
regulated dorsal target genes. This accounts for the uncoupling
of dorsal specification (prior to the 32-cell stage) from the onset
of target gene expression (MBT for siamois and xnr3). We have
investigated this from two perspectives. First, ChIP analysis
demonstrates that the b-catenin target genes siamois and xnr3
arrive at the MBT poised for activation, marked by initiating
RNA Pol II, H3K4me3, and H3K9/14ac. b-catenin activity, in
particular, is required for the ultimate establishment of
H3K4me3. Second, biochemical and functional analyses show
that b-catenin interacts with the H3R8 methyltransferase Prmt2
during dorsal specification and that Prmt2 activity is both neces-
sary and sufficient to drive dorsal development downstream of
b-catenin. Transcriptional poising occurs in eukaryotes from
yeast to mammals, including in several embryonic contexts
(Akkers et al., 2009; Baugh et al., 2009; Bernstein et al., 2006;
Guenther et al., 2007; Hargreaves et al., 2009; Muse et al.,
2007; Radonjic et al., 2005; Rougvie and Lis, 1988; Vastenhouw
et al., 2010; Zeitlinger et al., 2007); here, we illustrate how a crit-
ical developmental signaling pathway, acting through a gene-
specific transcription factor, poises genetic loci for expression
at a later time in development.
Drosophila heat shock genes are the most well understood
examples of poised genetic loci. Initially, ‘‘pioneer factors’’
(such as trithorax-like/GAGA factor) function to open chromatin
and nucleate the assembly of the initiated (but stalled) RNA Pol
II holoenzyme (Lee et al., 1992, 2008; Shopland et al., 1995
and references therein). Following binding of ‘‘release factors’’
(such as Heat Shock Factor) that recruit elongation-promoting
factors such as CyclinT/Cdk9, RNA Pol II enters into productive
elongation (Lis et al., 2000 and references therein). Our work
does not suggest that b-catenin functions as a pioneer factor:
in the absence of b-catenin function, target gene promoters
are nonetheless maintained in an ‘‘incompletely poised’’ state
containing stalled RNA Pol II and H3K9/14ac but not
H3K4me3. Rather, our work suggests that b-catenin functions
as part of the mechanism that establishes a ‘‘fully poised’’ state,(E) Prmt2:DNLef1 and Carm1:DNLef1 mRNAs (500 pg) were injected and
RT-PCR was performed as described for (C) and (D).
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Prmt2), ultimately resulting in the downstream establishment of
H3K4me3 in collaboration with RNA Pol II. Upon establishment
of a fully poised promoter, b-catenin target genes thereby
become receptive to transcriptional activation at the MBT. We
further speculate that the incompletely poised state of dorsal
target genes seen in the absence of b-catenin reflects the embry-
onic competency to activate the dorsal gene expression
program throughout the embryo.
Presetting Patterns of Gene Expression in the Embryo
The targets of the maternal Wnt/b-catenin pathway demonstrate
different latencies between dorsal specification and the onset of
gene expression. The preMBT genes xnr5 and xnr6 require addi-
tional input fromthematernal transcription factorVegT (Takahashi
et al., 2000). Thus, VegT could function as a ‘‘release factor’’ for
these genes, recruiting elongation-promoting factors to the xnr5
and xnr6 loci downstreamof b-catenin.On the other hand, factors
that regulate the global activation of the zygotic genome at the
MBT could be responsible for the release of the later responding
siamois and xnr3 genes. Indeed, transcriptional poising is an
attractive mechanism to account for the synchronous activation
of large-scale zygotic gene expression at the MBT. While such
global activating factors have yet to be identified in Xenopus, in
Drosophila, bothSmaugandZeldahavebeenshown tobeessen-
tial factors for zygoticgenomeactivation (Benoit et al., 2009; Liang
et al., 2008). Smaug activity is essential for the establishment of
elongating (CTD pSer2) RNA Pol II at the MBT, and could thereby
promote ‘‘release’’ of such preMBT poised loci, albeit indirectly
(Benoit et al., 2009). The mechanism of action for Zelda is
unknown, but it binds DNA sequences present in the majority of
immediate-early zygotic transcripts (Liang et al., 2008). Further
investigation is needed to determine the extent of transcriptional
poising at immediate-early zygotic loci and the mechanism of
action for such global zygotic gene activators at the MBT.
While preMBT Xenopus embryos are transcriptionally compe-
tent (Prioleau et al., 1994; Toyoda and Wolffe, 1992), several
overlapping mechanisms dominantly suppress zygotic gene
expression (Veenstra, 2002). Interfering with these repressive
activities can reveal a suppressed protranscriptional activity.
Depleting embryos of the DNA methyltransferase Dnmt1 causes
precocious expression of many genes, suggesting that these
genes are poised for activation prior to theMBT but are repressed
by Dnmt1-mediated DNA methylation (Stancheva and Meehan,
2000). Also, embryos generated from transplantation of transcrip-
tionally active nuclei will display preMBT expression of genes
that were active in the original donor cells (Ng and Gurdon,
2005). This transcriptionalmemory is linked tochromatinmodifica-
tions that correlate with active transcription, particularly the incor-
poration of the histone variant H3.3 (Ng and Gurdon, 2008). These
observationsdemonstrate the competencyof preMBTembryos to
establishandmaintainactive-but-repressedchromatin.We further
speculate that transcriptional poising is amajormechanismunder-
lying the activation of the zygotic genome at the MBT.
Are There Context-Dependent Chromatin Modifying
Activities for b-Catenin?
b-catenin can interact with a number of chromatin modifying
enzymes and may recruit additional factors to poised loci,228 Developmental Cell 19, 220–231, August 17, 2010 ª2010 Elsevieincluding H3K4 methyltransferases or, at the MBT, elongation
promoting factors (Mosimann et al., 2006; Sierra et al., 2006).
As hypothesized byMosimann et al. (2009), ‘‘cofactor switching’’
of b-catenin is an attractive model to account for the numerous
possible interactions between b-catenin and its coactivators,
yet has proven difficult to dissect at the molecular level. A recent
genome-wide screen for b-catenin interactors in colorectal
carcinoma cell lines (Major et al., 2008) confirmed several of
these interactions and identified novel complex members,
including the H4 arginine HMT Prmt1. Carm1 also interacts
with b-catenin in the context of androgen receptor signaling
(Koh et al., 2002). In preMBT embryos, b-catenin interacts with
Prmt2, but not with Carm1 or Prmt1, suggesting that the b-cate-
nin/chromatin remodeling complex associates with different
Prmt family members in a context-dependent manner. Addition-
ally, in colon cancer cell lines, the b-catenin/chromatin remodel-
ing complex contains theMLL family of H3K4 HMTs (Major et al.,
2008; Sierra et al., 2006). Our analysis indicates that, in early
Xenopus embryos, the primary HMT activity associated with
b-catenin is directed at H3R8, but the possibility remains that
b-catenin interacts with MLL family members in later develop-
mental stages. A systematic comparison of these complexes
from diverse developmental stages will be necessary to investi-
gate this possibility further.
Notably, after the 32-cell stage, siamois and xnr3 expression
becomes ‘‘locked in’’ and resistant to inhibition of b-catenin/
Tcf transactivation. Establishment of poised chromatin architec-
ture is an attractive model to account for this observation.
DNTcf3 functions by inhibiting Tcf3 binding to chromatin (Tutter
et al., 2001), thereby excluding b-catenin from its genomic loci.
However, another cofactor of b-catenin, Pygopus, binds methyl-
ated H3K4 via its PHD domain (Fiedler et al., 2008) and is also
essential for dorsal specification (Belenkaya et al., 2002). This
suggests an attractive model where, following establishment of
poised chromatin architecture prior to the 32-cell stage, Pygo-
pus could function as a Tcf3-independent tether for b-catenin
at poised target genes (de la Roche and Bienz, 2007; Fiedler
et al., 2008). Additionally, since poised loci can also behave as
chromatin insulators (Chopra et al., 2009), the poised chromatin
architecture of the siamois and xnr3 loci could serve the dual
purpose of marking these genes for activation at the MBT and
insulating them from downregulation by transcriptional repres-
sors, such as nonliganded Tcf3.
H3R8 Methylation and the Histone Code
A remaining question is what role asymmetric H3R8 methylation
plays in either the establishment or maintenance of poised
chromatin architecture, in particular H3K4 methylation. The
histone code hypothesis postulates that histone modifications
function combinatorially to regulate events such as transcrip-
tional activation (Strahl and Allis, 2000). Thus, H3R8 methylation
could recruit downstream complexes containing an H3K4 HMT,
resulting in the subsequent methylation of H3K4. Although
factors that ‘‘read’’ H3R8me2a have yet to be identified, histone
arginine methylation influences the patterns of histone tail
modifications (Bedford and Clarke, 2009). Alternatively, H3R8
methylation could inhibit the activity of a repressive factor,
such as an H3K4 demethylase, which would otherwise maintain
transcriptional repression. In support of this model, H3R8r Inc.
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et al., 2006). In addition, we observe that b-catenin-mediated
H3R8 methylation is sensitive to the modification state of K9,
as also observed for the symmetric H3R8 HMT Prmt5 (Pal
et al., 2004). Similarly, Prmt1, whose methylation of histone
H4R3 potentiates downstream H4 acetylation, will not methylate
a preacetylated H4 tail (Wang et al., 2001). Conversely, H3K9
methylation by the HMT G9a is inhibited by methylation of
H3R8 (Rathert et al., 2008). These observations suggest that
H3 R8 and K9 antagonism represents a critical regulatory node
underlying the interpretation of the histone code, where asym-
metric methylation of R8 activates and K9 represses gene
expression. Antagonistic H3K9methylation could thus represent
a mechanism to restrict the expression domains of dorsal deter-
minants in early embryos.
In conclusion, we have demonstrated how a developmental
signaling pathway plays an instructive role in the establishment
of poised chromatin architecture, linking with chromatin regula-
tory mechanisms to preset gene expression programs in the
embryo. Future investigations will focus on how the constellation
of chromatin marks established at promoters before the MBT
function to regulate the initial patterns of embryonic gene
expression.
EXPERIMENTAL PROCEDURES
Embryo Manipulations
Embryos were obtained, cultured, and microinjected as described (Sive et al.,
2000). Capped mRNAs were produced by in vitro transcription using the SP6
mMessage mMachine Kit (Ambion). b-catenin morpholino (Heasman et al.,
2000) was injected separately from mRNA to prevent precipitation.
Plasmid Construction
cDNAs for mouse Prmt2, 5, 6, and Carm1 were PCR-amplified from I.M.A.G.E.
Consortium [LLNL] clones (Open Biosystems) (Lennon et al., 1996) and subcl-
oned into pCS2+MT.
RT-PCR
Radiolabeled RT-PCR was performed as described (Yang et al., 2002b) using
GoTaq Flexi polymerase (Promega). Purified RNA (5 embryos/sample) was
DNase treated and repurified by RNeasy (QIAGEN). Two and a half micro-
grams total RNA was used per cDNA synthesis reaction.
Chromatin Immunoprecipitation
ChIP was performed as described (Blythe et al., 2009) with 50 embryos per
IP and either radiolabeled PCR or SYBR green QPCR. Anti-N-b-catenin was
described in Blythe et al., (2009). Purchased antibodies included anti-
H3acK9/14 and -H3K4me3 (Millipore #06-599 and #07-473), anti-Pol II
p-Ser5 (Active Motif #39233), anti-Pol II p-Ser2 (Abcam #Ab5095), H3K9me1
and H3K9me3 (Millipore 07-450 & 07-442), H3R8me2a (Active Motif
#39651), and anti-Myc epitope (Sigma #C3956). The anti-H3R8me2s antibody
was kindly provided by Dr. Said Sif (Ohio State University) (Pal et al., 2004). For
primer information, see Supplemental Experimental Procedures.
Peptide Synthesis
Unmodified and R8me2a H3 (1-15+C) peptides were synthesized by the
Proteomics Resource Center of the Rockefeller University. Unmodified H3
1-21, H3K9ac 1-20, and H3K9me3 1-24 peptides were from AnaSpec.
Anti-H3R8me2a
H3R8me2a antiserum was generated by immunizing rabbits with H3R8me2a
(1-15+C) peptide coupled to KLH (Cocalico Biologicals). This antiserum was
depleted of antibodies to unmodified H3 and affinity purified with the
R8me2a peptide. The limit of detection was 8 pmol H3R8me2a (1-15) byDevelopdot blot. Results were duplicated with H3R8me2a antiserum from Active Motif
(39651) (see Figure S2G).
Immunoprecipitations
Embryos were homogenized in HM 0.1 M buffer (Sierra et al., 2006), supple-
mented with protease inhibitor cocktail (Sigma P8340) and phosphatase
inhibitor cocktail I and II (Sigma P2850 and P5726). Insoluble material was
pelleted by centrifugation (14,000 3 g) for 10 min at 4C. Supernatants were
adjusted to 0.15 mM KCl and 0.2% NP-40 and filtered through a 0.45 mm
cellulose acetate syringe filter (Millipore) prior to addition of antibodies.
Immune complexes precipitated with recombinant protein G agarose were
washed five times in wash buffer (HMZ 0.15 M) (Sierra et al., 2006) prior to
IP/HMT analysis or western blot.
Histone Methyltransferase Assays
HM 0.1 M lysates of 8- to 32-cell embryos were immunoprecipitated and
processed for IP/HMT assays as described (Sierra et al., 2006) (see Supple-
mental Experimental Procedures) using 50mMTris-HCl (pH 8.8) in the reaction
buffer. Five micrograms calf thymus histones, 2.5 mg recombinant HA-H3.3, or
5 mg synthetic peptide was used as substrates. IP/HMT reactions typically
generated <1 pmol of in-vitro-labeled substrate.
Maternal Depletion of Prmt2
Maternal depletions were performed as described (Mir and Heasman, 2008).
Antisense DNA (1 ng/nl) against Prmt2 mRNA (GenBank HM205111) was
injected vegetally into defolliculated oocytes at the indicated doses. Control
and antisense injected oocytes were incubated for 24 hr prior to in vitro
maturation (2 mM progesterone, 10 hr) and transfer to an egg-laying host.
Transferred eggs were collected in high-salt buffer for 4 hr following transplan-
tation prior to in vitro fertilization. For mRNA rescue experiments, 10 nl of
mouse Prmt2 mRNA (100 pg/nl) was injected vegetally shortly before oocyte
maturation. The sequence of the Prmt2 antisense oligo is: 50-TCC GTT CTG
TAT CTC TCC-30.
ACCESSION NUMBERS
The sequence for Xenopus laevis prmt2 has been deposited in GenBank
(HM205111).
SUPPLEMENTAL INFORMATION
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and three figures and can be found with this article online at doi:10.1016/j.
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